Learn how stool appearance can signal colon cancer. Recognize signs like ribbon-like and pebble-shaped stools, and understand when to seek medical advice.

I had rectal bleeding, the most common symptom of colon cancer in people under 45. I also had a family history of colon cancer, which pushed me to get a colonoscopy at 33. My out-of-pocket colonoscopy ...

October 9, 2008 — Stool DNA testing is a new approach to screening for colorectal cancer, but it is an evolving technology. A study has found that the first-generation stool DNA test (SDT-1) is not ...

Your digestive system works quietly behind the scenes, but when something goes wrong with your colon, early detection can be lifesaving. Many serious conditions develop gradually, making it easy to ...

Stool DNA testing climbed sharply after the pandemic began while colonoscopy and fecal immunochemical test use fell, a study of nearly 25 million privately insured Blue Cross Blue Shield beneficiaries ...

Kentucky has long carried one of the highest burdens of colorectal cancer in the nation. For too many families, it is a diagnosis that comes too late and with too few effective treatment options. But ...

An investigational multitarget stool DNA test for screening colorectal cancer detects significantly more cancers than the currently available fecal immunochemical test (FIT), researchers report. But ...

Automatically mailing a stool test kit to people's homes might be the best way to boost colon cancer screening among younger adults, a new study says. More 45- to 49-year-olds went ahead with cancer ...

Cologuard is a colon cancer screening test you can do at home. It’s a noninvasive, stool-based test that comes in a kit. You use the kit to collect a stool sample. Then you send the sample to a lab ...

DALLAS — Dr. Bethany Malone has treated a lot of colorectal cancer patients. The youngest, not counting those with genetic conditions, was 19 years old. Colorectal cancer used to be considered a ...

We compared a noninvasive, multitarget stool DNA test with a fecal immunochemical test (FIT) in persons at average risk for colorectal cancer. The DNA test includes quantitative molecular assays for ...